{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T03:08:02Z","timestamp":1788664082163,"version":"build-2803163510"},"reference-count":63,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,3,1]]},"abstract":"<jats:p>OBJECTIVE. Postnatal steroids (PNSs) are used frequently to prevent or treat chronic lung disease (CLD) in the very low birth weight (VLBW) infant, and their use continues despite concerns regarding an increased incidence of longer-term neurodevelopmental abnormalities in such infants. More recently, there has been a suggestion that corticosteroids may be a useful alternative therapy for hypotension in VLBW infants, but there have been no prospective reports of such use for a current cohort of VLBW infants.<\/jats:p><jats:p>METHODS. The California Perinatal Quality Care Collaborative (CPQCC) requested members to supplement their routine Vermont Oxford Network data collection with additional information on any VLBW infant treated during their hospital course with PNS, for any indication. The indication, actual agent used, total initial daily dose, age at treatment, type of respiratory support, mean airway pressure, fraction of inspired oxygen, and duration of first dosing were recorded.<\/jats:p><jats:p>RESULTS. From April 2002 to March 2003 in California, 22 of the 62 CPQCC hospitals reported supplemental data, if applicable, from a cohort of 1401 VLBW infants (expanded data group [EDG]), representing 33.2% of the VLBW infants registered with the CPQCC during the 12-month period. PNSs for CLD were administered to 8.2% of all VLBW infants in 2003, 8.6% of infants in the 42 hospitals that did not submit supplemental data (routine data-set group, compared with 7.6% in EDG hospitals). Of the 1401 VLBW infants in the EDG, 19.3% received PNSs; 3.6% received PNSs for only CLD, 11.8% for only non-CLD indications, and 4.0% for both indications. At all birth weight categories, non-CLD use was significantly greater than CLD use. The most common non-CLD indication was hypotension, followed by extubation stridor, for which 36 (16.3%) infants were treated. For hypotension, medications used were hydrocortisone followed by dexamethasone. Infants treated with PNSs exclusively for hypotension had a significantly higher incidence of intraventricular hemorrhage, periventricular leukomalacia, and death when compared with infants treated only for CLD or those who did not receive PNSs.<\/jats:p><jats:p>CONCLUSIONS. The common early use of hydrocortisone for hypotension and the high morbidity and mortality in children receiving such treatment has not been recognized previously and prospective trials evaluating the short- and long-term risk\/benefit of such treatment are urgently required.<\/jats:p>","DOI":"10.1542\/peds.2005-0796","type":"journal-article","created":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T19:23:43Z","timestamp":1141241023000},"page":"704-713","source":"Crossref","is-referenced-by-count":59,"title":["Prospective Evaluation of Postnatal Steroid Administration: A 1-Year Experience From the California Perinatal Quality Care Collaborative"],"prefix":"10.1542","volume":"117","author":[{"given":"Neil N.","family":"Finer","sequence":"first","affiliation":[{"name":"Department of Neonatology, University of California San Diego Medical Center, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Powers","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Childrens Hospital and Research Center, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-hao Simon","family":"Ou","sequence":"additional","affiliation":[{"name":"Department of Neonatal and Developmental Pediatrics, California Perinatal Quality Care Collaborative, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Durand","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Childrens Hospital and Research Center, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wirtschafter","sequence":"additional","affiliation":[{"name":"Perinatal Quality Improvement Panel, California Perinatal Quality Care Collaborative, Southern California Permanente Medical Group, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey B.","family":"Gould","sequence":"additional","affiliation":[{"name":"Department of Neonatal and Developmental Pediatrics, California Perinatal Quality Care Collaborative, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the California Perinatal Quality Care Collaborative Executive Committee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2006,3,1]]},"reference":[{"key":"2021120820114317000_R1","doi-asserted-by":"crossref","unstructured":"Haddad H, Hsia D, Gellis S. Studies on respiratory rate in the newborn: its use in the evaluation of RDS in IDM. Pediatrics.\u20081956;17:204\u2013213","DOI":"10.1542\/peds.17.2.204"},{"key":"2021120820114317000_R2","unstructured":"Altman H. The respiratory distress syndrome of the newborn: a report of 135 cases treated conservatively. S Afr Med J.\u20081965;39:746\u2013748"},{"key":"2021120820114317000_R3","doi-asserted-by":"crossref","unstructured":"Baden M, Bauer CR, Colle E, et al. A controlled trial of hydrocortisone therapy in infants with RDS. Pediatrics.\u20081972;50:526\u2013534","DOI":"10.1542\/peds.50.4.526"},{"key":"2021120820114317000_R4","doi-asserted-by":"crossref","unstructured":"Ewerbech H, Helwig H. Treatment of idiopathic respiratory distress with large doses of corticoids. Pediatrics.\u20081972;49:467\u2013468","DOI":"10.1542\/peds.49.3.467"},{"key":"2021120820114317000_R5","doi-asserted-by":"crossref","unstructured":"Bhuta T, Ohlsson A. Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease. Arch Dis Child Fetal Neonatal Ed.\u20081998;79:F26\u2013F33","DOI":"10.1136\/fn.79.1.F26"},{"key":"2021120820114317000_R6","doi-asserted-by":"crossref","unstructured":"Halliday HL. Clinical trials of postnatal corticosteroids: inhaled and systemic. Biol Neonate.\u20081999;76:29\u201340","DOI":"10.1159\/000047044"},{"key":"2021120820114317000_R7","doi-asserted-by":"crossref","unstructured":"Halliday HL, Ehrenkranz RA, Doyle LW. Early postnatal (&lt;96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev.\u20082003;(1):CD001146","DOI":"10.1002\/14651858.CD001146"},{"key":"2021120820114317000_R8","doi-asserted-by":"crossref","unstructured":"Halliday HL, Ehrenkranz RA, Doyle LW. Moderately early (7\u201314 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev.\u20082003;(1):CD001144","DOI":"10.1002\/14651858.CD001144"},{"key":"2021120820114317000_R9","doi-asserted-by":"crossref","unstructured":"Halliday HL, Ehrenkranz RA, Doyle LW. Delayed (&gt;3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev.\u20082003;(1):CD001145","DOI":"10.1002\/14651858.CD001145"},{"key":"2021120820114317000_R10","doi-asserted-by":"crossref","unstructured":"Finer NN, Craft A, Vaucher YE, et al. Postnatal steroids: short-term gain, long-term pain? J Pediatr.\u20082000;137:9\u201313","DOI":"10.1067\/mpd.2000.107799"},{"key":"2021120820114317000_R11","doi-asserted-by":"crossref","unstructured":"Weichsel ME. The therapeutic use of glucocorticoid hormones in the perinatal period: potential neurological hazards. Ann Neurol.\u20081977;46:364\u2013366","DOI":"10.1002\/ana.410020503"},{"key":"2021120820114317000_R12","doi-asserted-by":"crossref","unstructured":"Benesova O, Pavlik A. Perinatal treatment with glucocorticoids and the risk of maldevelopment of the brain. Neuropharmacology.\u20081989;28:89\u201397","DOI":"10.1016\/0028-3908(89)90073-7"},{"key":"2021120820114317000_R13","doi-asserted-by":"crossref","unstructured":"Vicedomini JP, Nonneman AJ, DeKosky ST, et al. Perinatal glucocorticoids disrupt learning: a sexually dimorphic response. Physiol Behav.\u20081986;36:145\u2013149","DOI":"10.1016\/0031-9384(86)90088-0"},{"key":"2021120820114317000_R14","doi-asserted-by":"crossref","unstructured":"Huang WL, Beazley LD, Quinlivan JA, et al. Effect of corticosteroids on brain growth in fetal sheep. Obstet Gynecol.\u20081999;94:213\u2013218","DOI":"10.1097\/00006250-199908000-00011"},{"key":"2021120820114317000_R15","unstructured":"Quinlivan JA, Dunlop SA, Newnham JP, et al. Repeated, but not single, maternal administration of corticosteroids delays myelination in the brain of fetal sheep. Prenat Neonatal Med.\u20081999;4:47\u201355"},{"key":"2021120820114317000_R16","doi-asserted-by":"crossref","unstructured":"Uno H, Lohmiller L, Thieme C, et al. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. 1. Hippocampus. Dev Brain Res.\u20081990;53:157\u2013167","DOI":"10.1016\/0165-3806(90)90002-G"},{"key":"2021120820114317000_R17","doi-asserted-by":"crossref","unstructured":"Blackmon LR, Bell EF, Engle WA, et al. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics.\u20082002;109:330\u2013338","DOI":"10.1542\/peds.109.2.330"},{"key":"2021120820114317000_R18","unstructured":"Vermont Oxford Network. 2001 Database Summary. Burlington, VT: Vermont Oxford Network; 2003"},{"key":"2021120820114317000_R19","unstructured":"Stark AR, Carlo W, Bauer C, et al. Complications of early steroid therapy in a randomized controlled trial [abstract]. Pediatrics.\u20081999;104:739A"},{"key":"2021120820114317000_R20","unstructured":"Soll RF; Vermont Oxford Network Steroid Study Group. Early postnatal dexamethasone therapy for the prevention of chronic lung disease [abstract]. Pediatr Res.\u20081999;42:123A"},{"key":"2021120820114317000_R21","doi-asserted-by":"crossref","unstructured":"Papile LA, Tyson JE, Stoll BJ, et al. A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants. N Engl J Med.\u20081998;338:1112\u20131118","DOI":"10.1056\/NEJM199804163381604"},{"key":"2021120820114317000_R22","doi-asserted-by":"crossref","unstructured":"Stoll BJ, Temprosa M, Tyson JE, et al. Dexamethasone therapy increases infection in very low birth weight infants. Pediatrics. 1999;104(5). Available at: www.pediatrics.org\/cgi\/content\/full\/104\/5\/e63","DOI":"10.1542\/peds.104.5.e63"},{"key":"2021120820114317000_R23","doi-asserted-by":"crossref","unstructured":"Amin SB, Sinkin RA, McDermott MP, et al. Lipid intolerance in neonates receiving dexamethasone for bronchopulmonary dysplasia. Arch Pediatr Adolesc Med.\u20081999;153:795\u2013800","DOI":"10.1001\/archpedi.153.8.795"},{"key":"2021120820114317000_R24","doi-asserted-by":"crossref","unstructured":"Van Goudoever JB, Wattimena JD, Carnielli VP, Sulkers EJ, Degenhart HJ, Sauer PJ. Effect of dexamethasone on protein metabolism in infants with bronchopulmonary dysplasia. J Pediatr.\u20081994;124:112\u2013118.","DOI":"10.1016\/S0022-3476(94)70265-9"},{"key":"2021120820114317000_R25","doi-asserted-by":"crossref","unstructured":"Leitch CA, Ahlrichs J, Karn C, Denne SC. Energy expenditure and energy intake during dexamethasone therapy for chronic lung disease. Pediatr Res.\u20081999;46:109\u2013113","DOI":"10.1203\/00006450-199907000-00018"},{"key":"2021120820114317000_R26","doi-asserted-by":"crossref","unstructured":"Berry MA, Abrahamowicz M, Usher RH. Factors associated with growth of extremely premature infants during initial hospitalization. Pediatrics.\u20081997;100:640\u2013646","DOI":"10.1542\/peds.100.4.640"},{"key":"2021120820114317000_R27","doi-asserted-by":"crossref","unstructured":"Rizvi ZB, Aniol HS, Myers TF, et al. Effects of dexamethasone on the hypothalamic-pituitary-adrenal axis in preterm infants. J Pediatr.\u20081992;120:961\u2013965","DOI":"10.1016\/S0022-3476(05)81971-7"},{"key":"2021120820114317000_R28","doi-asserted-by":"crossref","unstructured":"Ng PC, Blackburn ME, Brownlee KG, et al. Adrenal response in very low birthweight babies after dexamethasone treatment for bronchopulmonary dysplasia. Arch Dis Child.\u20081989;64:1721\u20131726","DOI":"10.1136\/adc.64.12.1721"},{"key":"2021120820114317000_R29","doi-asserted-by":"crossref","unstructured":"Kari MA, Heinonen K, Ikonen RS, Koivisto M, Raivio KO. Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia. Arch Dis Child.\u20081993;68:566\u2013569","DOI":"10.1136\/adc.68.5_Spec_No.566"},{"key":"2021120820114317000_R30","doi-asserted-by":"crossref","unstructured":"Shinwell ES, Karplus M, Reich D, et al. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed.\u20082000;83:F177\u2013F181","DOI":"10.1136\/fn.83.3.F177"},{"key":"2021120820114317000_R31","doi-asserted-by":"crossref","unstructured":"Barrington KJ. The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs. BMC Pediatr.\u20082001;1:1","DOI":"10.1186\/1471-2431-1-1"},{"key":"2021120820114317000_R32","doi-asserted-by":"crossref","unstructured":"Doyle LW, Halliday HL, Ehrenkranz RA, et al. Impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk for chronic lung disease. Pediatrics.\u20082005;115:655\u2013661","DOI":"10.1542\/peds.2004-1238"},{"key":"2021120820114317000_R33","doi-asserted-by":"crossref","unstructured":"Helbock HJ, Insoft RM, Conte FA. Glucocorticoid-responsive hypotension in extremely low birth weight neonates. Pediatrics.\u20081993;92:715\u2013717","DOI":"10.1542\/peds.92.5.715"},{"key":"2021120820114317000_R34","doi-asserted-by":"crossref","unstructured":"Bourchier D, Weston PJ. Randomised trial of dopamine compared with hydrocortisone for the treatment of hypotensive very low birthweight infants. Arch Dis Child Fetal Neonatal Ed.\u20081997;76:F174\u2013F178","DOI":"10.1136\/fn.76.3.F174"},{"key":"2021120820114317000_R35","doi-asserted-by":"crossref","unstructured":"Mammel MC, Green TP, Johnson DE, Thompson TR. Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia. Lancet.\u20081983;1:(8338)1356\u20131358","DOI":"10.1016\/S0140-6736(83)92139-6"},{"key":"2021120820114317000_R36","doi-asserted-by":"crossref","unstructured":"Truffert P, Empana JP, Breart G, et al. Treatment strategies for bronchopulmonary dysplasia with postnatal corticosteroids in Europe: the EURAIL survey. Acta Paediatr.\u20082003;92:948\u2013951","DOI":"10.1080\/08035250310002579"},{"key":"2021120820114317000_R37","doi-asserted-by":"crossref","unstructured":"Williams O, Greenough A. Post-natal corticosteroid use. Eur J Pediatr.\u20082003;162:613\u2013615","DOI":"10.1007\/s00431-003-1273-0"},{"key":"2021120820114317000_R38","unstructured":"Wirtschafter DD, Murphy B, Nisbet CC. for the California Perinatal Quality Care Collaborative. Postnatal Steroid Administration Quality Improvement Toolkit. 2003. Available at: www.cpqcc.org\/PNS.html. Accessed February 25, 2005"},{"key":"2021120820114317000_R39","unstructured":"Walsh MC, Yao O, Horbar JD, et al. Changes in postnatal steroid (PNS) use in VLBW neonates in 3 large neonatal networks. Pediatr Acad Soc.\u20082005;57:2078"},{"key":"2021120820114317000_R40","doi-asserted-by":"crossref","unstructured":"Romagnoli C, Latella C, Zecca E, Papacci P, Tortorolo G. Adrenocortical function and chronic lung disease of pre-maturity: an unresolved problem? J Endocrinol Invest.\u20082002;25:759\u2013764","DOI":"10.1007\/BF03345508"},{"key":"2021120820114317000_R41","doi-asserted-by":"crossref","unstructured":"Watterberg KL, Scott SM, Backstrom C, et al. Links between early adrenal function and respiratory outcome in preterm infants: airway inflammation and patent ductus arteriosus. Pediatrics.\u20082000;105:320\u2013324","DOI":"10.1542\/peds.105.2.320"},{"key":"2021120820114317000_R42","doi-asserted-by":"crossref","unstructured":"Watterberg KL, Gerdes JS, Gifford KL, Lin HM. Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants. Pediatrics.\u20081999;104:1258\u20131263","DOI":"10.1542\/peds.104.6.1258"},{"key":"2021120820114317000_R43","doi-asserted-by":"crossref","unstructured":"Watterberg KL, Gerdes JS, Cole C, et al. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Pediatrics.\u20082004;114:1649\u20131657","DOI":"10.1542\/peds.2004-1159"},{"key":"2021120820114317000_R44","doi-asserted-by":"crossref","unstructured":"Demarini S, Dollberg S, Hoath SB, et al. Effects of antenatal corticosteroids on blood pressure in very low birth weight infants during the first 24 hours of life. J Pathol.\u20081999;19:419\u2013425","DOI":"10.1038\/sj.jp.7200245"},{"key":"2021120820114317000_R45","doi-asserted-by":"crossref","unstructured":"Smith LM, Ervin MG, Wada N, et al. Antenatal glucocorticoids alter postnatal preterm lamb renal and cardiovascular responses to intravascular volume expansion. Pediatr Res.\u20082000;47:622\u2013627","DOI":"10.1203\/00006450-200005000-00011"},{"key":"2021120820114317000_R46","doi-asserted-by":"crossref","unstructured":"Ng PC, Lee CH, Lam CW, et al. Transient adrenocortical insufficiency of prematurity and systemic hypotension in very low birthweight infants. Arch Dis Child.\u20082004;89:119\u2013126","DOI":"10.1136\/adc.2002.021972"},{"key":"2021120820114317000_R47","doi-asserted-by":"crossref","unstructured":"Dasgupta SJ, Gill AB. Hypotension in the very low birthweight infant: the old, the new, and the uncertain. Arch Dis Child Fetal Neonatal Ed.\u20082003;88:F450\u2013F454","DOI":"10.1136\/fn.88.6.F450"},{"key":"2021120820114317000_R48","doi-asserted-by":"crossref","unstructured":"Hall RW, Kronsberg SS, Barton BA, Kaiser JR, Anand KJ; NEOPAIN Trial Investigators Group. Morphine, hypotension, and adverse outcomes among preterm neonates: who\u2019s to blame? Secondary results from the NEOPAIN trial. Pediatrics.\u20082005;115:1351\u20131359","DOI":"10.1542\/peds.2004-1398"},{"key":"2021120820114317000_R49","doi-asserted-by":"crossref","unstructured":"Osborn D, Evans N, Kluckow M. Randomized trial of dobutamine versus dopamine in preterm infants with low systemic blood flow. J Pediatr.\u20082002;140:183\u2013191","DOI":"10.1067\/mpd.2002.120834"},{"key":"2021120820114317000_R50","doi-asserted-by":"crossref","unstructured":"Kluckow M, Evans N. Superior vena cava flow in newborn infants: a novel marker of systemic blood flow. Arch Dis Child Fetal Neonatal Ed.\u20082000;82:F182\u2013F187","DOI":"10.1136\/fn.82.3.F182"},{"key":"2021120820114317000_R51","doi-asserted-by":"crossref","unstructured":"Osborn DA, Evans N, Kluckow M. Hemodynamic and antecedent risk factors of early and late periventricular\/intraventricular hemorrhage in premature infants. Pediatrics.\u20082003;112:33\u201339","DOI":"10.1542\/peds.112.1.33"},{"key":"2021120820114317000_R52","doi-asserted-by":"crossref","unstructured":"Evans N, Kluckow M, Simmons M, et al. Which to measure, systemic or organ blood flow? Middle cerebral artery and superior vena cava flow in very preterm infants. Arch Dis Child.\u20082002;87:181\u2013184","DOI":"10.1136\/fn.87.3.F181"},{"key":"2021120820114317000_R53","doi-asserted-by":"crossref","unstructured":"Seri I, Tan R, Evans J. Cardiovascular effects of hydrocortisone in preterm infants with pressor-resistant hypotension. Pediatrics.\u20082001;107:1070\u20131074","DOI":"10.1542\/peds.107.5.1070"},{"key":"2021120820114317000_R54","doi-asserted-by":"crossref","unstructured":"Gaissmaier RE, Pohlandt F. Single-dose dexamethasone treatment of hypotension preterm infants. J Pediatr.\u20081999;134:701\u2013705","DOI":"10.1016\/S0022-3476(99)70284-2"},{"key":"2021120820114317000_R55","doi-asserted-by":"crossref","unstructured":"Zhang J, Penny DJ, Kim NS, Yu VY, Smolich JJ. Mechanisms of blood pressure increase induced by dopamine in hypotensive preterm neonates. Arch Dis Child Fetal Neonatal Ed.\u20081999;81:F99\u2013F104","DOI":"10.1136\/fn.81.2.F99"},{"key":"2021120820114317000_R56","doi-asserted-by":"crossref","unstructured":"Bauer K, Linderkamp O, Versmold HT. Systolic blood pressure and blood volume in preterm infants. Arch Dis Child.\u20081993;69:521\u2013522","DOI":"10.1136\/adc.69.5_Spec_No.521"},{"key":"2021120820114317000_R57","doi-asserted-by":"crossref","unstructured":"Aladangady N, Aitchison TC, Beckett C, Holland BM, Kyle BM, Wardrop CA. Is it possible to predict the blood volume of a sick preterm infant? Arch Dis Child Fetal Neonatal Ed.\u20082004;89:F344\u2013F347","DOI":"10.1136\/adc.2003.039008"},{"key":"2021120820114317000_R58","doi-asserted-by":"crossref","unstructured":"Gill AB, Weindling AM. Randomised controlled trial of plasma protein fraction versus dopamine in hypotensive very low birthweight infants. Arch Dis Child.\u20081993;69:284\u2013287","DOI":"10.1136\/adc.69.3_Spec_No.284"},{"key":"2021120820114317000_R59","doi-asserted-by":"crossref","unstructured":"Pladys P, Wodey E, Betremieux P, et al. Effects of volume expansion on cardiac output in the preterm infant. Acta Paediatr.\u20081997;86:1241\u20131245","DOI":"10.1111\/j.1651-2227.1997.tb14854.x"},{"key":"2021120820114317000_R60","doi-asserted-by":"crossref","unstructured":"Mayock DE, Gleason CA. Cerebrovascular effects of rapid volume expansion in preterm fetal sheep. Pediatr Res.\u20082004;55:395\u2013399","DOI":"10.1203\/01.PDR.0000111284.29388.E7"},{"key":"2021120820114317000_R61","doi-asserted-by":"crossref","unstructured":"Lindner W, Vossbeck S, Hummler H, et al. Delivery room management of extremely low birthweight infants: spontaneous breathing or intubation? Pediatrics.\u20081999;103:961\u2013967","DOI":"10.1542\/peds.103.5.961"},{"key":"2021120820114317000_R62","doi-asserted-by":"crossref","unstructured":"Verder H, Albertsen P, Ebbesen F, et al. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks\u2019 gestation. Pediatrics.\u20081999;103(2). Available at: www.pediatrics.org\/cgi\/content\/full\/103\/2\/e24","DOI":"10.1542\/peds.103.2.e24"},{"key":"2021120820114317000_R63","doi-asserted-by":"crossref","unstructured":"Barrington KJ, Bull D, Finer NN. Randomized trial of nasal synchronized intermittent mandatory ventilation compared with continuous positive airway pressure after extubation of very low birth weight infants. Pediatrics.\u20082001;107:638\u2013641","DOI":"10.1542\/peds.107.4.638"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/117\/3\/704\/1071345\/zpe00306000704.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/117\/3\/704\/1071345\/zpe00306000704.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T16:45:58Z","timestamp":1683391558000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/117\/3\/704\/68587\/Prospective-Evaluation-of-Postnatal-Steroid"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,1]]},"references-count":63,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2006,3,1]]},"published-print":{"date-parts":[[2006,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2005-0796","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,1]]}}}